ArriVent BioPharma (AVBP) Institutional Ownership → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free AVBP Stock Alerts $20.10 -0.05 (-0.25%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media Institutional Ownership Changes (13F Filings) for ArriVent BioPharma (NASDAQ:AVBP)CurrentInstitutional OwnershipPercentage9.48%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$92.30MNumber ofInstitutional Sellers(last 12 months)0 Get AVBP Insider Trade Alerts Want to know when executives and insiders are buying or selling ArriVent BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AVBP Institutional Buying and Selling by Quarter Ad True Market Insidersget a piece of the profit from this land This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024. ArriVent BioPharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2024 Blackstone Inc.25,000$446K0.0%N/A0.075% 5/15/2024 Hhlr Advisors LTD.3,929,117$70.17M1.5%N/A11.732% 5/15/2024 Altitude Crest Partners Inc.555,555$9.92M4.2%N/A1.659% 5/14/2024 American International Group Inc.4,845$87K0.0%N/A0.014% 5/10/2024 Vanguard Group Inc.648,735$11.59M0.0%N/A1.937% 5/1/2024 BNP Paribas Financial Markets4,659$83K0.0%N/A0.014% (Data available from 1/1/2016 forward) AVBP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AVBP shares? During the previous two years, the following institutional investors and hedge funds held shares of ArriVent BioPharma shares: Hhlr Advisors LTD. ($70.17M), Vanguard Group Inc. ($11.59M), Altitude Crest Partners Inc. ($9.92M), Blackstone Inc. ($446K), and American International Group Inc. ($87K), BNP Paribas Financial Markets ($83K).Learn more on AVBP's institutional investors. What percentage of ArriVent BioPharma stock is owned by institutional investors? 9.48% of ArriVent BioPharma stock is owned by institutional investors. Learn more on AVBP's institutional investor holdings. Which institutional investors have been buying ArriVent BioPharma stock? The following institutional investors have purchased ArriVent BioPharma stock in the last 24 months: Hhlr Advisors LTD. ($3.93M), Vanguard Group Inc. ($648.74K), Altitude Crest Partners Inc. ($555.56K), Blackstone Inc. ($25K), American International Group Inc. ($4.85K), and BNP Paribas Financial Markets ($4.66K). How much institutional buying is happening at ArriVent BioPharma? Institutional investors have bought a total of 5,167,911 shares in the last 24 months. This purchase volume represents approximately $92.30M in transactions. Related Companies: Lyell Immunopharma Institutional Ownership Zymeworks Institutional Ownership Silence Therapeutics Institutional Ownership GH Research Institutional Ownership Pharvaris Institutional Ownership Calliditas Therapeutics AB (publ) Institutional Ownership AnaptysBio Institutional Ownership Mineralys Therapeutics Institutional Ownership Savara Institutional Ownership Pharming Group Institutional Ownership This page (NASDAQ:AVBP) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBill Gates is all about this tiny $2 stockTimothy SykesCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressMan who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.”InvestorPlaceForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the Markets[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ArriVent BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
